Pancreatic exocrine insufficiency. IV. The enzyme content of commercial pancreatic supplements.
D000681:Amylases / Q000032:analysis*; D004353:Drug Evaluation, Preclinical; D006801:Humans; D066298:In Vitro Techniques; D008049:Lipase / Q000032:analysis*; D010182:Pancreatic Diseases / Q000188:drug therapy*; D010184:Pancreatic Extracts / Q000592:standards* / Q000627:therapeutic use; D010447:Peptide Hydrolases / Q000032:analysis*; D014357:Trypsin / Q000032:analysis*; D014362:Trypsinogen / Q000032:analysis*
D010184:Pancreatic Extracts; D014362:Trypsinogen; D008049:Lipase; D000681:Amylases; D010447:Peptide Hydrolases; D014357:Trypsin